Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation.
Clin Cancer Res
; 25(20): 6035-6043, 2019 10 15.
Article
en En
| MEDLINE
| ID: mdl-31337643
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Nucleósidos de Pirimidina
/
Fármacos Sensibilizantes a Radiaciones
/
Quimioradioterapia
/
Neoplasias Gastrointestinales
/
Idoxuridina
Límite:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Año:
2019
Tipo del documento:
Article